AMH and polycystic ovary syndrome: The degree of AMH reduction varies among women, depending on baseline insulin resistance, severity of PCOS, and individual responsiveness to metformin.Personalizing metformin therapy by regularly measuring AMH levels ensures more targeted and effective management of PCOS and IR.